Medicus Pharma (MDCX) Stock Price, News & Analysis

Company Overview

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.

Key Stats

• Today's Range: $2.60 to $2.74
• 50-Day Range: $2.31 to $2.99
• 52-Week Range: $1.80 to $6.00
• Volume: 3,199 shs
• Average Volume: 12,050 shs
• Market Capitalization: $29.50 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.00
• Consensus Rating: Strong Buy

MDCX Stock Analysis - Frequently Asked Questions

How have MDCX shares performed this year?

Medicus Pharma's stock was trading at $2.43 on January 1st, 2025. Since then, MDCX shares have increased by 11.9% and is now trading at $2.72.
View the best growth stocks for 2025 here.

How were Medicus Pharma's earnings last quarter?

Medicus Pharma Ltd. (NASDAQ:MDCX) announced its quarterly earnings data on Friday, November, 22nd. The company reported ($0.31) earnings per share for the quarter.

When did Medicus Pharma IPO?

Medicus Pharma (MDCX) raised $4 million in an IPO on Thursday, November 14th 2024. The company issued 1,000,000 shares at a price of $4.13 per share. Maxim Group LLC served as the underwriter for the IPO and Brookline Capital Markets was co-manager.

How do I buy shares of Medicus Pharma?

Shares of MDCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 11/22/2024
• Today: 1/30/2025
• Next Earnings (Estimated): 2/28/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:MDCX
• Previous Symbol: NASDAQ:MDCX
• CUSIP: N/A
• CIK: 1997296
• Web: www.medicuspharma.com
• Phone: 732-300-3046
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $10.00
• High Stock Price Target: $10.00
• Low Stock Price Target: $10.00
• Potential Upside/Downside: +250.9%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 3.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 10,847,000
• Free Float: N/A
• Market Cap: $30.91 million
• Optionable: N/A
• Beta: N/A